PODD

Insulet

$311.69

+2.58 (+0.83%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 07.10.2025
$362.00
(+16.14%)
Strong Buy: 5
Buy: 16
Hold: 3
Sell: 0
Strong Sell: 0
Description:
Insulet Corporation (PODD) specializes in the development and manufacturing of innovative insulin delivery systems for individuals with insulin-dependent diabetes, aimed at enhancing patient quality of life and managing health outcomes. Headquartered in Acton, Massachusetts, Insulet is best known for its Omnipod® Insulin Management System, which offers a tubeless, wearable pump solution that promotes greater flexibility and ease of use for patients. With a strong commitment to improving diabetes management, the company continues to advance its technology portfolio and expand its global reach, positioning itself as a leader in the diabetes care market.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
100 NAGOG PARK, ACTON, MA, UNITED STATES, 01720
Fiscal year end:
December
Market capitalization:
$21.8 Billion
EBITDA:
$481 Million
PERatio:
94.24
EPS:
3.28
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.399

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+1092%
How much will you get:
$11,915
Prices dates:
30-09-2015: $25.91 and 30-09-2025: $308.73